Early Diagnosis of Alzheimer’s Disease

– Alzheimer’s disease (AD), a progressive neurodegenerative disorder, significantly impacts millions worldwide. Early diagnosis is crucial for effective intervention and management, yet current diagnostic approaches often detect the disease at advanced stages, limiting treatment efficacy. This paper explores advanced methodologies for the early detection of Alzheimer’s disease, leveraging artificial intelligence (AI), machine learning (ML), and biomarker analysis. By integrating neuroimaging techniques, such as magnetic resonance imaging (MRI) and positron emission tomography (PET), with ML algorithms, early-stage biomarkers of cognitive decline can be identified with greater precision. Furthermore, genetic markers, cerebrospinal fluid (CSF) analysis, and cognitive tests are combined to develop a holistic diagnostic framework. Emerging technologies like natural language processing (NLP) and also utilization and analysis.(MRI) and positron emission tomography (PET), with ML algorithms, early-stage biomarkers of cognitive decline can be identified with greater precision. Furthermore, genetic markers, cerebrospinal fluid (CSF) analysis, and cognitive tests are combined to develop a holistic diagnostic framework. Emerging technologies like  natural language processing (NLP) are also utilized to analyze speech and linguistic patterns as potential indicators of cognitive impairment. The study highlights the importance of multi-modal data.